Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 119

1.

Hypertrophic cardiomyopathy: the edge-to-edge secures the correction of the systolic anterior motion.

Obadia JF, Basillais N, Armoiry X, Grinberg D, Dondas A, Barthelet M, Derimay F, Rioufol G, Finet G, Pozzi M.

Eur J Cardiothorac Surg. 2016 Dec 22. pii: ezw385. doi: 10.1093/ejcts/ezw385. [Epub ahead of print]

PMID:
28007871
2.

FFR in daily clinical practice: from "Prêt-à-Porter" to "Haute Couture".

Finet G, Rioufol G.

EuroIntervention. 2016 Dec 10;12(11):e1322-e1324. doi: 10.4244/EIJV12I11A219. No abstract available.

3.

A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.

Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA, Curzen N, Piroth Z, Rioufol G, Jüni P, De Bruyne B.

J Am Coll Cardiol. 2016 Nov 29;68(21):2247-2255. doi: 10.1016/j.jacc.2016.08.055.

PMID:
27884241
4.

Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.

Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Dos Santos P, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Laskar M, Iung B; FRANCE 2 Investigators..

J Am Coll Cardiol. 2016 Oct 11;68(15):1637-1647. doi: 10.1016/j.jacc.2016.07.747.

PMID:
27712776
5.

Fractional flow reserve in France: Free access at last?

Rioufol G, Finet G.

Arch Cardiovasc Dis. 2016 Oct;109(10):514-516. doi: 10.1016/j.acvd.2016.04.008. No abstract available.

PMID:
27692508
6.

1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.

Douglas PS, De Bruyne B, Pontone G, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chiswell K, Cyr D, Wilk A, Wang F, Rogers C, Hlatky MA; PLATFORM Investigators..

J Am Coll Cardiol. 2016 Aug 2;68(5):435-45. doi: 10.1016/j.jacc.2016.05.057.

PMID:
27470449
7.

Routine Fractional Flow Reserve Combined to Diagnostic Coronary Angiography as a One-Stop Procedure: Episode 3.

Van Belle E, Dupouy P, Rioufol G.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e004137. doi: 10.1161/CIRCINTERVENTIONS.116.004137. No abstract available.

PMID:
27412871
8.

Sequential Proximal Optimizing Technique in Provisional Bifurcation Stenting With Everolimus-Eluting Bioresorbable Vascular Scaffold: Fractal Coronary Bifurcation Bench for Comparative Test Between Absorb and XIENCE Xpedition.

Derimay F, Souteyrand G, Motreff P, Guerin P, Pilet P, Ohayon J, Darremont O, Rioufol G, Finet G.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1397-406. doi: 10.1016/j.jcin.2016.04.021.

PMID:
27388830
9.

Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment.

Johnson NP, Jeremias A, Zimmermann FM, Adjedj J, Witt N, Hennigan B, Koo BK, Maehara A, Matsumura M, Barbato E, Esposito G, Trimarco B, Rioufol G, Park SJ, Yang HM, Baptista SB, Chrysant GS, Leone AM, Berry C, De Bruyne B, Gould KL, Kirkeeide RL, Oldroyd KG, Pijls NH, Fearon WF.

JACC Cardiovasc Interv. 2016 Apr 25;9(8):757-67. doi: 10.1016/j.jcin.2015.12.273.

10.

1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.

Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):376-84. doi: 10.1016/j.jcin.2015.10.024.

11.

Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.

Souteyrand G, Amabile N, Mangin L, Chabin X, Meneveau N, Cayla G, Vanzetto G, Barnay P, Trouillet C, Rioufol G, Rangé G, Teiger E, Delaunay R, Dubreuil O, Lhermusier T, Mulliez A, Levesque S, Belle L, Caussin C, Motreff P; PESTO Investigators..

Eur Heart J. 2016 Apr 14;37(15):1208-16. doi: 10.1093/eurheartj/ehv711.

PMID:
26757787
12.

Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM.

Hlatky MA, De Bruyne B, Pontone G, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Wilk A, Wang F, Rogers C, Douglas PS; PLATFORM Investigators..

J Am Coll Cardiol. 2015 Dec 1;66(21):2315-23. doi: 10.1016/j.jacc.2015.09.051.

13.

Rationale and design of the Prospective LongitudinAl Trial of FFRCT: Outcome and Resource IMpacts study.

Pontone G, Patel MR, Hlatky MA, Chiswell K, Andreini D, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, de Bruyne B, Rogers C, Douglas PS.

Am Heart J. 2015 Sep;170(3):438-46.e44. doi: 10.1016/j.ahj.2015.06.002.

PMID:
26385026
14.

Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.

Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chiswell K, Cyr D, Wilk A, Wang F, Rogers C, De Bruyne B; PLATFORM Investigators..

Eur Heart J. 2015 Dec 14;36(47):3359-67. doi: 10.1093/eurheartj/ehv444.

15.

Cyclosporine before PCI in Patients with Acute Myocardial Infarction.

Cung TT, Morel O, Cayla G, Rioufol G, Garcia-Dorado D, Angoulvant D, Bonnefoy-Cudraz E, Guérin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Claeys MJ, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, De Poli F, Morice MC, Ider O, Dubois-Randé JL, Unterseeh T, Le Breton H, Béard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Elmer E, Hansson MJ, Bergerot C, Boussaha I, Jossan C, Derumeaux G, Mewton N, Ovize M.

N Engl J Med. 2015 Sep 10;373(11):1021-31. doi: 10.1056/NEJMoa1505489.

16.

Comparative Analysis of Sequential Proximal Optimizing Technique Versus Kissing Balloon Inflation Technique in Provisional Bifurcation Stenting: Fractal Coronary Bifurcation Bench Test.

Finet G, Derimay F, Motreff P, Guerin P, Pilet P, Ohayon J, Darremont O, Rioufol G.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):1308-17. doi: 10.1016/j.jcin.2015.05.016.

17.

Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction.

Pichot S, Mewton N, Bejan-Angoulvant T, Roubille F, Rioufol G, Giraud C, Boussaha I, Lairez O, Elbaz M, Piot C, Angoulvant D, Ovize M.

Open Heart. 2015 Aug 6;2(1):e000175. doi: 10.1136/openhrt-2014-000175.

18.

Primary PCI with or without Thrombectomy.

Rioufol G, Finet G.

N Engl J Med. 2015 Aug 13;373(7):681. doi: 10.1056/NEJMc1507110#SA3. No abstract available.

PMID:
26267633
19.

Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients.

Schaaf MJ, Mewton N, Rioufol G, Angoulvant D, Cayla G, Delarche N, Jouve B, Guerin P, Vanzetto G, Coste P, Morel O, Roubille F, Elbaz M, Roth O, Prunier F, Cung TT, Piot C, Sanchez I, Bonnefoy-Cudraz E, Revel D, Giraud C, Croisille P, Ovize M.

J Cardiol. 2016 Mar;67(3):248-53. doi: 10.1016/j.jjcc.2015.05.008.

PMID:
26116981
20.

Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial).

Mewton N, Cung TT, Morel O, Cayla G, Bonnefoy-Cudraz E, Rioufol G, Angoulvant D, Guerin P, Elbaz M, Delarche N, Coste P, Vanzetto G, Metge M, Aupetit JF, Jouve B, Motreff P, Tron C, Labeque JN, Steg PG, Cottin Y, Range G, Clerc J, Coussement P, Prunier F, Moulin F, Roth O, Belle L, Dubois P, Barragan P, Gilard M, Piot C, Colin P, Morice MC, Monassier JP, Ider O, Dubois-Randé JL, Unterseeh T, Lebreton H, Beard T, Blanchard D, Grollier G, Malquarti V, Staat P, Sudre A, Hansson MJ, Elmer E, Boussaha I, Jossan C, Torner A, Claeys M, Garcia-Dorado D, Ovize M; CIRCUS Study Investigators..

Am Heart J. 2015 Jun;169(6):758-766.e6. doi: 10.1016/j.ahj.2015.02.020.

PMID:
26027612

Supplemental Content

Loading ...
Support Center